About LumiraDx
LumiraDx is a company based in Waltham (United States) founded in 2014 by Sumit Nagpal was acquired by Roche in January 2024. LumiraDx has raised $703.91 million across 9 funding rounds from investors including Roche, Capital One and Gates Foundation. The company has 9 employees as of March 27, 2024. LumiraDx offers products and services including LumiraDx Instrument and LumiraDx Assays. LumiraDx operates in a competitive market with competitors including EKF, SpinChip, LightDeck Diagnostics, Abaxis and EDX Medical Group, among others.
- Headquarter Waltham, United States
- Employees 9 as on 27 Mar, 2024
- Founders Sumit Nagpal
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lumiradx Healthcare Private Limited
- Date of Incorporation 07 Jul, 2021
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$115.02 K (USD)0as on Mar 31, 2022
-
Net Profit
$9.2 K (USD)0as on Mar 31, 2022
-
EBITDA
$17.76 K (USD)0as on Mar 31, 2022
-
Total Equity Funding
$703.91 M (USD)
in 9 rounds
-
Latest Funding Round
$14.2 M (USD), Grant
Dec 14, 2022
-
Investors
Roche
& 3 more
-
Employee Count
9
as on Mar 27, 2024
-
Acquired by
Roche
(Jan 02, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LumiraDx
LumiraDx offers a comprehensive portfolio of products and services, including LumiraDx Instrument and LumiraDx Assays.
Portable system for point-of-care assays and health testing
Tests for detecting diseases from various sample types
People of LumiraDx
Unlock access to complete
Unlock access to complete
Funding Insights of LumiraDx
LumiraDx has successfully raised a total of $703.91M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $14.2 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LumiraDx
LumiraDx has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Roche, Capital One and Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked | |
|
Provider of marketing services to biopharma sector
|
Locked | Locked | Locked | |
|
Provider of loans, credit cards, and savings services
|
Locked | Locked | Locked |
Investor details for LumiraDx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LumiraDx
Investment portfolio details for LumiraDx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LumiraDx
Detailed financials for LumiraDx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lumiradx Comparisons
Peer comparison for LumiraDx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LumiraDx
LumiraDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EKF, SpinChip, LightDeck Diagnostics, Abaxis and EDX Medical Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Point-of-care and laboratory blood analyzers are developed by EKF.
|
|
| Locked | Locked | Locked |
In-vitro diagnostic test cartridges are developed and manufactured via R&D.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for multiplex assays are developed.
|
|
| Locked | Locked | Locked |
Diagnostics company offering a comprehensive line of on-site diagnostic instruments and rapid tests
|
|
| Locked | Locked | Locked |
Medical diagnostics solutions are researched by the laboratory.
|
Detailed competitors of LumiraDx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lumiradx
Complete news archive for LumiraDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LumiraDx
LumiraDx was founded in 2014 and raised its 1st funding round 2 years after it was founded.
LumiraDx is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Sumit Nagpal is the current CEO of LumiraDx. They have also founded this company.
LumiraDx is a funded company, having raised a total of $703.91M across 9 funding rounds to date.
As of Mar 27, 2024, the latest employee count at LumiraDx is 9.
Annual revenue of LumiraDx is $115.02K as on Mar 31, 2022.
LumiraDx a healthcare solutions care management company specializing in the comprehensive support of individuals with chronic disease. The flagship software solutions called Consult allow health and social care providers to view and manage patient records that are always joined up across all venues of care, from the doctors office to a patients home. The patient-facing version of this software Engage allows individuals to view, manage, and share their own history from across all venues of care. Their platform also connects with a growing list of home and point-of-care diagnostic devices and personal biometric devices that record real-time activity including continuous heart rate, surface temperature, posture, sleep, stress levels and integrates this data into individual longitudinal records.
LumiraDx offers LumiraDx Instrument and LumiraDx Assays.
LumiraDx has 4 investors. Key investors include Roche, Capital One, Gates Foundation, and bpcruk.